The U.S. government has awarded a $5,702.85 fixed-price delivery order contract to Medtronic Inc., through its Medtronic USA, Inc. division, for the supply of Biologics - DBM-TS-OTI Grafton DBM Matrix medical products. This contract was awarded by the Defense Health Agency (DHA), a component of the Department of Defense (DoD) that oversees the Military Health System. The contract has an ultimate completion date of December 9, 2024 and does not have a set-aside designation. Medtronic is a...
The U.S. government has awarded a $3,790.50 fixed-price delivery order contract to Medtronic Inc., through its Medtronic USA, Inc. division, for the supply of BIOLOGICS - DBM-TS-GRAFTON DBF medical products. This contract was issued by the Defense Health Agency (DHA), a component of the Department of Defense. The contract has no set-aside designation and runs through July 10, 2024. Medtronic is a global leader in medical technology, providing a wide range of innovative medical devices and...
The U.S. government agency the Defense Health Agency (DHA) awarded a $2,875.65 fixed-price with economic price adjustment delivery order contract to Medtronic Inc., through its Medtronic USA, Inc. division, for the supply of BIOLOGICS - DBM-TS-OTI GRAFTON DBM MATRIX medical products. This contract does not have a set-aside designation. Medtronic is a global leader in medical technology, specializing in developing and manufacturing innovative medical devices and therapies. As a major supplier...
This is a federal contract award from the Defense Health Agency (DHA) to Medtronic Inc., through its Medtronic USA, Inc. division, for the delivery of BIOLOGICS - DBM-TS-MAGNIFUSE DBM medical devices. The contract is a Delivery Order with a fixed price and economic price adjustment, has a ceiling value of $14,820.00, and has a completion date of September 6, 2024. The contract is not designated as a set-aside. Medtronic, a global leader in medical technology, has a significant Indefinite...
Medtronic Inc., a global medical technology company, has been awarded a Delivery Order contract by the Defense Logistics Agency Troop Support Medical valued at $2,875.65. The contract is for the provision of Biologics - DBM-TS-OTI Grafton DBM Matrix, a surgical implant product. This order is not designated as a set-aside contract. The contract has a completion date of February 8, 2024 and was awarded on February 5, 2024. Medtronic Inc. has a long history of supplying medical devices and...
Medtronic Inc., a global medical technology company, was awarded a $19,418.00 fixed-price delivery order contract by the Defense Logistics Agency Troop Support Medical to provide Biologics - DBM-TS-Grafton DBF products. The contract does not have a set-aside designation and has a completion date of February 29, 2024. Medtronic is the prime contractor for this order, which is part of a larger $600 million Indefinite Delivery Contract the company holds with the U.S. Department of Veterans...
This is a delivery order contract awarded by the Defense Health Agency (DHA) to Medtronic Inc., a global leader in medical technology. The contract, valued at $6,098.05, is for the delivery of Biologics - DBM-TS-OTI Grafton Plus DBM, a specialized medical product. The contract is a fixed-price with economic price adjustment, and does not have a set-aside designation, indicating it was awarded through full and open competition. Medtronic's Medtronic USA, Inc. division is the prime contractor, and...
This federal contract award was issued by the Defense Health Agency (DHA), an agency within the Department of Defense (DoD), to Medtronic Inc. through its Medtronic USA, Inc. division. The $2,274.30 fixed-price contract with economic price adjustment is for the delivery of BIOLOGICS - DBM-TS-GRAFTON DBF medical products, which are likely specialized surgical implants or biologics used in the treatment of military personnel and veterans. The contract does not have a set-aside designation and is...
This federal contract award to Medtronic Inc., through its Medtronic USA, Inc. division, is a Delivery Order (SPE2DE21D7001|SPE2D624F2PV9) with a ceiling value of $4,940.00. The contract is for the delivery of BIOLOGICS - DBM-TS-MAGNIFUSE DBM products, and has a fixed price with economic price adjustment pricing type. The award was made by the Defense Health Agency (DHA), which is a defense agency, with a period of performance through July 9, 2024. The contract does not have a set-aside...
This federal contract award, valued at $2,875.65, was issued by the Defense Health Agency (DHA) to Medtronic Inc., a global leader in medical technology, through its Medtronic USA, Inc. division. The contract is for the supply of a Biologics - DBM-TS-OTI Grafton DBM Matrix product, which is a surgical implant used in various medical procedures. The contract has a fixed-price with economic price adjustment pricing type and an ultimate completion date of June 12, 2024. Medtronic is the prime...